Eyestar
Featured
News
By Simon at 06.16.2121VisionQuest Uses AI to Screen 40,000 Patients for Diabetic Retinopathy
News / blog
Filter articles:
News by product
Eyestar ↘
- VisionQuest Uses AI to Screen 40,000 Patients for Diabetic Retinopathy
- EyeStar Passes the 30,000-Patient Milestone for Diabetic Retinopathy Screening Using Artificial Intelligence
- The Challenges of Implementing a Nationwide Retina Screening Program
- VisionQuest Biomedical to Participate in Virtual Exhibit at the World Ophthalmology Congress 2020
- EyeStar Fulfills Need for Diabetic Retinopathy Screening in Bolivia
Aspire ↘
- VisionQuest Receives $2M from NIH to Commercialize AI for Cerebral Malaria Diagnosis
- The Challenges of Implementing a Nationwide Retina Screening Program
- Through the Looking Glass: Using Artificial Intelligence to Recognize Cerebral Malaria in African Children
- VisionQuest Biomedical to Participate in Virtual Exhibit at the World Ophthalmology Congress 2020
- Glad to Say Yes: VisionQuest Supports Safe Clinical Research during the COVID-19 Pandemic
Would you like to know more about VisionQuest Biomedical?
Join our e-mail list to receive news relatedto Artificial Intelligence and VisionQuest Biomedical. Our company is growing, and we look forward to sharing updates with you!